Đang hiển thị 1 - 13 kết quả của 13 cho tìm kiếm 'Jing Wang (14959256)', thời gian truy vấn: 0.01s Tinh chỉnh kết quả
  1. 1
    Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

    Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers Bằng Juliana Navarro-Yepes (17079059)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC Bằng Sonia A. Patel (15055688)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC Bằng Sonia A. Patel (15055688)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC Bằng Sonia A. Patel (15055688)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC Bằng Sonia A. Patel (15055688)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

    Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC Bằng Sonia A. Patel (15055688)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... Bằng Abdullah A. Osman (15056323)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... Bằng Abdullah A. Osman (15056323)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... Bằng Abdullah A. Osman (15056323)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... Bằng Abdullah A. Osman (15056323)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer

    Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer Bằng Kavya Ramkumar (16474203)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous C... Bằng Abdullah A. Osman (15056323)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma

    Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous... Bằng Abdullah A. Osman (15056323)

    Được phát hành 2025
    Tác giả khác:
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: